National Healthcare Corp (NHC) Stock Analysis and Metrics

National Healthcare

NYSE: NHC

$228.63 ▲ +3.99 (+1.78%)

At close: Jul 17, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap3.32 Bn

P/E26.26

P/S2.14

Div. Yield0.01

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)5.59

Add ratio to table…

About

National HealthCare Corporation operates skilled nursing facilities, assisted living facilities, independent living facilities, homecare and hospice agencies, and behavioral health hospitals. The company provides subacute and postacute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimers care, senior living services, home health care services, hospice services, and behavioral health services. In addition, it offers management, accounting and financial services, as well as insurance services to third party operators of health care facilities, and owns real estate that it leases to other operators. Its operations span nine states, primarily in the Southeastern and Midwestern regions of the United States.

National HealthCare Corporation generates revenue mainly from net patient revenues derived from its health care services, which accounted for 96.8% of net operating revenues in fiscal year 2025. The remaining 3.2% comes from other sources such as management fees (typically 6% of managed facilities net operating revenues), accounting and financial services fees, insurance premiums from its wholly owned subsidiaries, and rental income from owned properties leased to third parties. Medicare, Medicaid, managed care, and private pay are the primary payment sources for patient services, with Medicare representing 31% of net patient revenues in 2025.

The company operates through the following segments:.

• Inpatient services: This segment encompasses the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and behavioral health hospitals, delivering skilled nursing, rehabilitative, memory care, senior living, and psychiatric services to residents and patients.

• Homecare and hospice services: This segment provides home health care and hospice care through agencies that offer infusion therapy, wound care, physical, occupational and speech therapies, as well as palliative care for terminally ill patients across multiple states.

National HealthCare Corporation holds a solid position within the long term care and senior housing industry, competing with numerous local and regional operators in the markets it serves. While no single competitor dominates the broader Southeastern and Midwestern markets, the company differentiates itself through an integrated continuum of care that links skilled nursing, assisted living, independent living, home health, hospice, and behavioral health services. Its consistent Five Star quality ratings 62.5% of its skilled nursing facilities earned four or five stars in 2025, above the industry average of 38.6%, and its focus on rehabilitative and patient centered programs provide a competitive advantage in attracting referrals from hospitals and physicians.

The company’s customer base includes seniors requiring skilled nursing, assisted living, independent living, home health, hospice, and behavioral health services, as well as third party operators that purchase management, accounting, financial, and insurance services. No individual customer or related group accounts for a significant portion of revenues, reflecting a diversified payer mix across Medicare, Medicaid, managed care, and private pay sources.

Investment Thesis

▲ Bull case

NHC’s acquisition of the real estate from NHI for $560 million represents a transformational strategic shift that management is positioning as a long-term value creator, yet the market appears to be underestimating the embedded optionality in this deal. By transitioning from a lessee to an owner of 32 skilled nursing facilities and three independent living facilities across seven states, NHC gains full control over capital allocation decisions, enabling it to optimize facility investments, pursue targeted renovations, and align capital expenditures with demographic trends in high-growth Sun Belt markets where occupancy and reimbursement rates are more favorable. This ownership structure also eliminates lease escalation risks and provides collateral strength that could support future debt refinancing at lower rates, directly enhancing free cash flow conversion—a lever not fully reflected in current valuation multiples. The fact that NHC will continue to operate all but four Florida facilities under third-party leases post-close suggests a de-risked integration path, allowing management to focus on operational synergies rather than disruptive tenant transitions, which could unlock accretion faster than guided.
Despite the recent dividend increases—from 64 cents to 67 cents per share, representing a 4.7% quarterly hike—the market is overlooking NHC’s durable capacity to sustain and grow shareholder returns through its non-GAAP earnings trajectory. Adjusted diluted EPS rose from $4.93 in FY24 to $6.65 in FY25, a 35% increase driven by same-facility revenue growth of 8.4% and the accretive impact of the White Oak acquisition, demonstrating that core operating performance is strengthening even as GAAP results are tempered by non-cash equity portfolio fluctuations. This underlying profitability, combined with a disciplined capital allocation framework emphasized in both the NHI deal and the five-facility ownership purchase, suggests that free cash flow yield is improving steadily and could support dividend growth well above inflation, a trait rare in the capital-intensive long-term care sector where many peers are cutting payouts.
The demographic tailwinds driving demand for NHC’s continuum-of-care model—spanning skilled nursing, assisted living, homecare, and hospice—are structural and underappreciated in near-term trading sentiment. With the acquisition of NHI’s real estate, NHC now controls a geographically diversified portfolio in states like Florida, Tennessee, and Virginia, where aging populations are growing faster than national averages and where state Medicaid reimbursement reforms are beginning to favor integrated post-acute providers. This positions NHC to capture referrals across its full service suite, increasing length of stay and revenue per patient, particularly as its behavioral health hospitals and memory care units address rising comorbidity trends among seniors. Unlike competitors focused solely on skilled nursing, NHC’s vertically integrated platform allows it to monetize care transitions internally, a competitive moat that is not yet priced into the stock given its current valuation relative to peers.
NHC’s ability to deliver consistent adjusted earnings growth despite labor cost pressures reveals operational resilience that the market is failing to reward. The company reported adjusted net income growth of 10.9% in Q4 FY25 and 21.1% in Q1 FY26, even as wage inflation remains a sector-wide challenge, suggesting that its scale, centralized management services, and third-party administrative offerings are creating offsetting efficiencies. Furthermore, NHC’s pharmacy, rehabilitation, and homecare segments—often overlooked as low-margin add-ons—are becoming higher-margin differentiators as value-based care models expand, and their integration with facility operations improves patient outcomes and reduces avoidable hospitalizations, directly tying into Medicare Advantage and accountable care organization incentives that are growing in adoption.

NHC’s acquisition of the real estate from NHI for $560 million represents a transformational strategic shift that management is positioning as a long-term value creator, yet the market appears to be underestimating the embedded optionality in this deal. By transitioning from a lessee to an owner of 32 skilled nursing facilities and three independent living facilities across seven states, NHC gains full control over capital allocation decisions, enabling it to optimize facility investments, pursue targeted renovations, and align capital expenditures with demographic trends in high-growth Sun Belt markets where occupancy and reimbursement rates are more favorable. This ownership structure also eliminates lease escalation risks and provides collateral strength that could support future debt refinancing at lower rates, directly enhancing free cash flow conversion—a lever not fully reflected in current valuation multiples. The fact that NHC will continue to operate all but four Florida facilities under third-party leases post-close suggests a de-risked integration path, allowing management to focus on operational synergies rather than disruptive tenant transitions, which could unlock accretion faster than guided.
Despite the recent dividend increases—from 64 cents to 67 cents per share, representing a 4.7% quarterly hike—the market is overlooking NHC’s durable capacity to sustain and grow shareholder returns through its non-GAAP earnings trajectory. Adjusted diluted EPS rose from $4.93 in FY24 to $6.65 in FY25, a 35% increase driven by same-facility revenue growth of 8.4% and the accretive impact of the White Oak acquisition, demonstrating that core operating performance is strengthening even as GAAP results are tempered by non-cash equity portfolio fluctuations. This underlying profitability, combined with a disciplined capital allocation framework emphasized in both the NHI deal and the five-facility ownership purchase, suggests that free cash flow yield is improving steadily and could support dividend growth well above inflation, a trait rare in the capital-intensive long-term care sector where many peers are cutting payouts.
The demographic tailwinds driving demand for NHC’s continuum-of-care model—spanning skilled nursing, assisted living, homecare, and hospice—are structural and underappreciated in near-term trading sentiment. With the acquisition of NHI’s real estate, NHC now controls a geographically diversified portfolio in states like Florida, Tennessee, and Virginia, where aging populations are growing faster than national averages and where state Medicaid reimbursement reforms are beginning to favor integrated post-acute providers. This positions NHC to capture referrals across its full service suite, increasing length of stay and revenue per patient, particularly as its behavioral health hospitals and memory care units address rising comorbidity trends among seniors. Unlike competitors focused solely on skilled nursing, NHC’s vertically integrated platform allows it to monetize care transitions internally, a competitive moat that is not yet priced into the stock given its current valuation relative to peers.
NHC’s ability to deliver consistent adjusted earnings growth despite labor cost pressures reveals operational resilience that the market is failing to reward. The company reported adjusted net income growth of 10.9% in Q4 FY25 and 21.1% in Q1 FY26, even as wage inflation remains a sector-wide challenge, suggesting that its scale, centralized management services, and third-party administrative offerings are creating offsetting efficiencies. Furthermore, NHC’s pharmacy, rehabilitation, and homecare segments—often overlooked as low-margin add-ons—are becoming higher-margin differentiators as value-based care models expand, and their integration with facility operations improves patient outcomes and reduces avoidable hospitalizations, directly tying into Medicare Advantage and accountable care organization incentives that are growing in adoption.

▼ Bear case

NHC’s $560 million real estate acquisition from NHI, while framed as accretive, introduces significant balance sheet risk that the market may be ignoring given the company’s limited historical use of leverage for such large-scale purchases. The transaction will likely require new debt issuance or drawing on existing credit facilities, increasing financial leverage at a time when interest rates remain elevated and the long-term care sector faces ongoing margin pressure from labor shortages and regulatory scrutiny. Although NHC cites expected accretion to earnings and cash flow, the company has not disclosed the assumed interest rate, debt structure, or payback period for this investment, leaving investors to rely on management’s optimism without visibility into sensitivity analyses—particularly if occupancy rates dip or Medicaid reimbursement delays occur in the acquired facilities post-close.
Despite consistent dividend increases, NHC’s payout ratio is rising to levels that may not be sustainable without continued non-GAAP earnings growth, and the market is overlooking the growing divergence between GAAP and adjusted metrics as a potential red flag. In FY25, GAAP net income was $120 million while adjusted net income was $104 million, a difference of $16 million largely driven by unrealized gains in the marketable equity securities portfolio—a volatile, non-operational component that can reverse quickly in market downturns. If equity markets correct, these non-GAAP adjustments could evaporate, exposing a thinner core earnings base and raising questions about whether the dividend, now at an annualized rate of $2.56 per share, is being funded by sustainable operations or temporary market tailwinds.
The long-term care industry is facing structural headwinds that NHC’s operational scale may not fully mitigate, particularly regarding labor availability and wage inflation, which remain persistent despite the company’s scale advantages. While NHC reports same-facility revenue growth of 8.4% in FY25, this figure includes the impact of the White Oak acquisition and may overstate organic strength; meanwhile, operating expenses continue to rise faster than revenue in key categories like salaries and benefits, which represented over 60% of operating costs in recent periods. The company’s reliance on third-party staffing agencies and ongoing reports of facility-level staffing shortages suggest that labor costs could remain a drag on margins, especially if federal or state mandates increase minimum staffing ratios—a policy trend gaining traction in several states where NHC operates.
NHC’s growth strategy is increasingly dependent on acquisitions and real estate ownership, yet the market may be underestimating the integration and execution risks inherent in scaling a geographically dispersed portfolio through purchase rather than organic development. The NHI deal involves 35 facilities across seven states, each with distinct state regulatory environments, payer mixes, and local labor market dynamics—complexities that NHC has not detailed in its integration plan beyond stating it will continue operations. Without clear milestones for standardization of care protocols, IT systems, or administrative oversight, there is risk that acquired facilities underperform relative to legacy assets, particularly if management bandwidth is stretched across multiple concurrent initiatives, including the recent five-facility ownership purchase and ongoing hospice and homecare expansion.
Regulatory uncertainty surrounding Medicare and Medicaid reimbursement remains a material, underappreciated risk that could disproportionately affect NHC given its high reliance on government payers. Although NHC discloses this risk in its forward-looking statements, the market may not be pricing in the potential impact of impending payment reforms, such as the proposed skilled nursing value-based purchasing program or Medicaid payment cuts tied to state budget shortfalls—especially in states like Missouri and Kentucky where NHC has significant footprint. Any reduction in per diem rates or shift toward outcome-based payments could pressure margins before NHC has fully optimized its newly acquired assets, and the company has not provided specific guidance on how it plans to adapt its cost structure or care delivery model in response to such changes, leaving investors exposed to a binary outcome.

NHC’s $560 million real estate acquisition from NHI, while framed as accretive, introduces significant balance sheet risk that the market may be ignoring given the company’s limited historical use of leverage for such large-scale purchases. The transaction will likely require new debt issuance or drawing on existing credit facilities, increasing financial leverage at a time when interest rates remain elevated and the long-term care sector faces ongoing margin pressure from labor shortages and regulatory scrutiny. Although NHC cites expected accretion to earnings and cash flow, the company has not disclosed the assumed interest rate, debt structure, or payback period for this investment, leaving investors to rely on management’s optimism without visibility into sensitivity analyses—particularly if occupancy rates dip or Medicaid reimbursement delays occur in the acquired facilities post-close.
Despite consistent dividend increases, NHC’s payout ratio is rising to levels that may not be sustainable without continued non-GAAP earnings growth, and the market is overlooking the growing divergence between GAAP and adjusted metrics as a potential red flag. In FY25, GAAP net income was $120 million while adjusted net income was $104 million, a difference of $16 million largely driven by unrealized gains in the marketable equity securities portfolio—a volatile, non-operational component that can reverse quickly in market downturns. If equity markets correct, these non-GAAP adjustments could evaporate, exposing a thinner core earnings base and raising questions about whether the dividend, now at an annualized rate of $2.56 per share, is being funded by sustainable operations or temporary market tailwinds.
The long-term care industry is facing structural headwinds that NHC’s operational scale may not fully mitigate, particularly regarding labor availability and wage inflation, which remain persistent despite the company’s scale advantages. While NHC reports same-facility revenue growth of 8.4% in FY25, this figure includes the impact of the White Oak acquisition and may overstate organic strength; meanwhile, operating expenses continue to rise faster than revenue in key categories like salaries and benefits, which represented over 60% of operating costs in recent periods. The company’s reliance on third-party staffing agencies and ongoing reports of facility-level staffing shortages suggest that labor costs could remain a drag on margins, especially if federal or state mandates increase minimum staffing ratios—a policy trend gaining traction in several states where NHC operates.
NHC’s growth strategy is increasingly dependent on acquisitions and real estate ownership, yet the market may be underestimating the integration and execution risks inherent in scaling a geographically dispersed portfolio through purchase rather than organic development. The NHI deal involves 35 facilities across seven states, each with distinct state regulatory environments, payer mixes, and local labor market dynamics—complexities that NHC has not detailed in its integration plan beyond stating it will continue operations. Without clear milestones for standardization of care protocols, IT systems, or administrative oversight, there is risk that acquired facilities underperform relative to legacy assets, particularly if management bandwidth is stretched across multiple concurrent initiatives, including the recent five-facility ownership purchase and ongoing hospice and homecare expansion.
Regulatory uncertainty surrounding Medicare and Medicaid reimbursement remains a material, underappreciated risk that could disproportionately affect NHC given its high reliance on government payers. Although NHC discloses this risk in its forward-looking statements, the market may not be pricing in the potential impact of impending payment reforms, such as the proposed skilled nursing value-based purchasing program or Medicaid payment cuts tied to state budget shortfalls—especially in states like Missouri and Kentucky where NHC has significant footprint. Any reduction in per diem rates or shift toward outcome-based payments could pressure margins before NHC has fully optimized its newly acquired assets, and the company has not provided specific guidance on how it plans to adapt its cost structure or care delivery model in response to such changes, leaving investors exposed to a binary outcome.

Segments Breakdown of Revenue (2024)

Peer Comparison

Companies in the Medical Care Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	HCA	HCA Healthcare, Inc.	87.94 Bn	11.25	1.15	48.02 Bn
2	CHE	Chemed Corp	18.08 Bn	51.68	7.12	0.09 Bn
3	THC	Tenet Healthcare Corp	16.59 Bn	9.74	0.77	13.21 Bn
4	DVA	Davita Inc.	15.37 Bn	14.02	1.10	10.63 Bn
5	EHC	Encompass Health Corp	10.07 Bn	654.20	1.66	2.57 Bn
6	ENSG	Ensign Group, Inc	9.52 Bn	27.18	1.81	0.14 Bn
7	UHS	Universal Health Services Inc	9.19 Bn	6.05	0.52	4.71 Bn
8	PACS	PACS Group, Inc.	6.96 Bn	28.55	1.28	0.05 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer Comparison

Create an account

Sign In

Reset Password